• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Fewer hospital admissions and death were seen with SARS-CoV-2 Delta (B.1.617.2) compared to Omicron (B.1.1.529) variant infections

byMinjee Kim
April 27, 2022
in StudyGraphics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. The risk of hospitalization and death was lower among cases infected with Omicron variant compared to Delta.

2. In unvaccinated cases, prior COVID-19 infection provided moderate protection.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Delta (B.1.617.2) and omicron (B.1.1.529) are two major identified variants of the COVID-19 pandemic. This retrospective cohort study aimed to characterize the difference in severity between the two variants for different age groups. Using a comprehensive database of individual patient data for all positive cases in England, this study compiled data of all laboratory-confirmed delta and omicron infections before January 24, 2022. Risk of hospitalization and death was shown to be lower in omicron cases versus delta cases. Compared to vaccinated cases, unvaccinated cases showed a greater risk reduction for hospitalization in the delta variant cases. This may suggest a reduction in vaccination effectiveness for the omicron variant compared to delta. Secondary outcomes measured by this study included severity by age, which showed that the greatest variation between delta and omicron was seen in the older population. Additionally, prior infection was shown to reduce the risk of hospitalization and death comparable to receiving one dose of an mRNA vaccine. Limitations of this study include the inability to control for testing rates between delta and omicron variants. Nonetheless, this study was a large-scale analysis which provides important information regarding the ongoing COVID-19 pandemic and further demonstrates the need for detailed surveillance.

Click to read the study in the Lancet

RELATED REPORTS

Worsening kidney function observed following SARS-CoV-2 infection in children

The Scan by 2 Minute Medicine®: Climate-Driven Crises, Serena’s Mental Fitness Revolution, Superhuman Immunity, and Healthcare on Strike

Increased blood–urea–nitrogen-to-albumin ratio associated with increased mortality in coronavirus disease

Relevant Reading: Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

In-Depth [retrospective cohort study]: This retrospective cohort study used data reported to the UK Health Security Agency (UKHSA) for all positive cases in England. Individuals included in the study had laboratory-confirmed SARS-CoV-2 infection of either S-gene positive (delta) or S-gene negative (omicron) variants before Dec 30, 2021. After this date, the prevalence of S-gene positive omicron (BA.2) lineage was increasing, thus making S-gene positivity less predictive of delta. 1 516 702 of the 4 135 347 (37%) of the identified SARS-CoV-2 cases met the criteria for inclusion with 448 843 delta and 1 067 859 omicron. 1.3% of delta cases and 9.6% of omicron cases were re-infections of individuals who had tested positive 90 days prior. Risk of hospital admission up to 14 days after a positive test was lower in omicron cases (Hazard ratio [HR] 0.41, 95% CI 0.39-0.43), as well as risk of death up to 28 days after a positive test (HR 0.31, 0.29-0.37). When stratifying for age, the HR was 1.10 for admission in individuals younger than 10 and substantially below 1 when looking at older age groups. When analyzing only unvaccinated cases, the reduction in risk of hospitalization between delta and omicron was greater (HR 0.30, 0.28-0.32). Additionally, reduction in risk of hospitalization between the vaccinated versus unvaccinated was greater for delta than omicron cases. Past infections were shown to reduce the risk of hospitalization (HR 0.55, 0.48-0.63) and death (HR 0.18, 0.06-0.57) in the unvaccinated.

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: #COVID mortality#COVID vaccinationcovidCOVID hospitalizationcovid immunitycovid variantsdeltaomicronSARS-CoV-2
Previous Post

Oral tacrolimus noninferior to intravenous cyclophosphamide for lupus nephritis

Next Post

Risks associated with nonoperative management of uncomplicated pediatric appendicitis

RelatedReports

Being overweight and obese associated with increased incidence of chronic kidney disease
Chronic Disease

Worsening kidney function observed following SARS-CoV-2 infection in children

May 23, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: Climate-Driven Crises, Serena’s Mental Fitness Revolution, Superhuman Immunity, and Healthcare on Strike

May 7, 2025
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Hematology

Increased blood–urea–nitrogen-to-albumin ratio associated with increased mortality in coronavirus disease

February 10, 2025
Compliance-linked incentives increase infant immunizations rates in rural India
Chronic Disease

Safety of simultaneous vs sequential mRNA COVID-19 and inactivated influenza vaccines

November 17, 2024
Next Post
Unenhanced magnetic resonance imaging highly sensitive and specific for acute appendicitis

Risks associated with nonoperative management of uncomplicated pediatric appendicitis

#VisualAbstract: Ruxolitinib use may be associated with higher incidences of nonmelanoma skin cancers

#VisualAbstract: Trastuzumab does not improve survival in patients with esophageal adenocarcinoma with HER2 overexpression

Few older adolescents meet recommended levels of physical activity

Wellness Check: Exercise

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Living in a marginalized neighbourhood is associated with worse outcomes in patients with myocardial infarction
  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.